ARCHIVES

Younger Patients, More Advanced Stages, More Likely To Die From Breast Cancer

This article is from The Cancer Letter archive.

Vol. 27 No. 9 | September 24, 2004

Download PDF Visit The Full Archive

Related Articles

Tasigna Shows High Response, PFS Benefit Compared to Gleevec in Phase III CML Study

December 26, 2014

Assurances On Methods For Misconduct Reporting Required

December 1, 1989

Tasigna Shows Benefit Over Gleevec In Phase III Study for Ph+ CML In Chronic Phase

December 31, 2010

Regulatory Agencies: HCFA Proposes Physician Transfer Of Drug Discounts To Medicare, Insurers

April 3, 1998

Barakat Named Deputy Physician-in-Chief Of Memorial Sloan-Kettering’s Regional Care Network

October 18, 2013

In Brief: NCA to Hear Reports On Outstanding Investigator Awards, Defining QRA, P01 Guidelines, Gallow Work

May 6, 1983